NZ219609A - Assay methods for inhibin - Google Patents

Assay methods for inhibin

Info

Publication number
NZ219609A
NZ219609A NZ219609A NZ21960987A NZ219609A NZ 219609 A NZ219609 A NZ 219609A NZ 219609 A NZ219609 A NZ 219609A NZ 21960987 A NZ21960987 A NZ 21960987A NZ 219609 A NZ219609 A NZ 219609A
Authority
NZ
New Zealand
Prior art keywords
inhibin
assay methods
assay
methods
Prior art date
Application number
NZ219609A
Inventor
David Mark Robertson
Robert Ian Mclachlan
Kretser David Moritz De
Original Assignee
Univ Monash
Biotech Australia Pty Ltd
St Vincents Inst Med Res
Monash Medical Centre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Monash, Biotech Australia Pty Ltd, St Vincents Inst Med Res, Monash Medical Centre filed Critical Univ Monash
Publication of NZ219609A publication Critical patent/NZ219609A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
NZ219609A 1986-03-13 1987-03-13 Assay methods for inhibin NZ219609A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPH501986 1986-03-13

Publications (1)

Publication Number Publication Date
NZ219609A true NZ219609A (en) 1990-09-26

Family

ID=3771514

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ219609A NZ219609A (en) 1986-03-13 1987-03-13 Assay methods for inhibin

Country Status (8)

Country Link
EP (1) EP0260306A4 (en)
JP (1) JPS63503086A (en)
AU (1) AU599373B2 (en)
CA (1) CA1307736C (en)
IL (1) IL81889A0 (en)
NZ (1) NZ219609A (en)
WO (1) WO1987005702A1 (en)
ZA (1) ZA871844B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942220A (en) * 1990-03-16 1999-08-24 Chiron Corporation Inhibitor of cytokine activity and applications thereof
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9316369D0 (en) * 1993-08-06 1993-09-22 Surface Active Ltd Diagnostic method
GB9410345D0 (en) * 1994-05-24 1994-07-13 Univ Oxford Brookes Method of genetic testing
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
US6787311B1 (en) 1999-02-25 2004-09-07 Auckland Uniservices Limited Diagnosis of premature ovarian failure
JP4903036B2 (en) 2003-01-06 2012-03-21 アンジオケム・インコーポレーテッド Aprotinin and analogs as carriers that cross the blood brain barrier
CA2520711A1 (en) * 2003-03-28 2004-10-07 Prostate Diagnostics Pty. Ltd. Diagnosis of advanced cancer
ES2527634T3 (en) 2005-02-18 2015-01-27 Angiochem Inc. Aprotinin polypeptides to transport a compound through the blood-brain barrier
AU2006272405B2 (en) 2005-07-15 2013-02-07 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
AU2009304560A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of GLP-1 agonists and uses thereof
AU2009322043A1 (en) 2008-12-05 2011-07-07 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
CA2747220A1 (en) 2008-12-17 2010-06-24 Richard Beliveau Membrane type-1 matrix metalloprotein inhibitors and uses thereof
ES2729261T3 (en) 2009-04-20 2019-10-31 Angiochem Inc Ovarian cancer treatment using an anticancer agent conjugated to an Angiopep-2 analog
CA2766537A1 (en) 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
CA2989400A1 (en) 2015-06-15 2016-12-22 Angiochem Inc. Ang1005 for the treatment of leptomeningeal carcinomatosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
KR940004077B1 (en) * 1985-04-18 1994-05-11 바이오테크놀로지 오스트레일리아 프로프라이어터리 리밋티드 Recombinantinhbin
US4624944A (en) * 1985-06-14 1986-11-25 The Regents Of The University Of California Human seminal alpha-inhibins
US4740587A (en) * 1985-07-18 1988-04-26 The Salk Institute For Biological Studies Inhibin and method of purifying same
NZ231899A (en) * 1985-10-03 1991-07-26 Genentech Inc Human or porcine inhibin peptide compositions and dna encoding them

Also Published As

Publication number Publication date
CA1307736C (en) 1992-09-22
EP0260306A4 (en) 1990-09-26
ZA871844B (en) 1988-05-25
EP0260306A1 (en) 1988-03-23
WO1987005702A1 (en) 1987-09-24
AU7203687A (en) 1987-10-09
JPS63503086A (en) 1988-11-10
IL81889A0 (en) 1987-10-20
AU599373B2 (en) 1990-07-19

Similar Documents

Publication Publication Date Title
GB2197322B (en) Antibodies
GB8305197D0 (en) Assay methods
NZ219609A (en) Assay methods for inhibin
GB8705650D0 (en) Assay technique
GB2197323B (en) Antibodies
GB8623494D0 (en) Assay technique
GB8913474D0 (en) Assay method
GB8820052D0 (en) Assay device & method
GB8919411D0 (en) Assay method
GB8800292D0 (en) Assay method
GB8628108D0 (en) Riboflavin-linked assay
EP0248621A3 (en) Reagent for immunoassay
GB8621495D0 (en) Assay
GB8922909D0 (en) Assay method
GB8710074D0 (en) Antibodies
GB8624891D0 (en) Assay method
GB8624892D0 (en) Assay method
GB8724461D0 (en) Assay method
GB8727822D0 (en) Assay method
GB8724460D0 (en) Assay method
GB8717540D0 (en) Assay techniques & apparatus
GB8824493D0 (en) Assay method
GB8824490D0 (en) Assay method
GB8619113D0 (en) Assay techniques
GB8909106D0 (en) Assay method